# Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

> **NCT00471471** · PHASE1 · COMPLETED · sponsor: **Ahmad Tarhini** · enrollment: 22 (actual)

## Conditions studied

- Intraocular Melanoma
- Malignant Conjunctival Neoplasm
- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** Peptide vaccine
- **BIOLOGICAL:** GM-CSF
- **BIOLOGICAL:** PF3512676

## Key facts

- **NCT ID:** NCT00471471
- **Lead sponsor:** Ahmad Tarhini
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471471, "Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00471471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*